STLN
Starling Oncology Inc.
STLN | NASDAQ
$6.53
-$0.12 (-1.80%)
At close: Oct 30, 2026, 3:59 PM ET
$6.62
+$0.09 (+1.38%)
Pre-market:
Nov 2, 2026, 7:09 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
PE Ratio | -10.74 |
PEG Ratio | n/a |
PS Ratio | 1.07 |
PB Ratio | -34.09 |
P/FCF Ratio | -19.28 |
P/OCF Ratio | -21.79 |
OCF/S Ratio | -4.89 |
Debt / Equity Ratio | -6.60 |
Quick Ratio | 1.35 |
Current Ratio | 1.59 |
Asset Turnover | 3.05 |
Interest Coverage | -3.20 |
Return on Equity | 385.53% |
Return on Assets | -36.81% |
Return on Invested Capital | -35.70% |
Dividend Yield | n/a |
Payout Ratio | n/a |
FCF Payout Ratio | n/a |
Gross Profit Margin | 15.20% |
Net Profit Margin | -12.06% |
Pretax Profit Margin | -12.08% |
Operating Profit Margin | -7.18% |
FCF Margin | -5.53% |
EBITDA Margin | -8.46% |
Add to Watchlist
Select watchlists to add or remove STLN